phthalocyanine has been researched along with Hypoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, T; Huang, JD; Jeon, YH; Kim, HR; Kwon, N; Lee, DS; Li, X; Park, JG; Yoon, J | 1 |
| Guo, X; Jin, H; Lo, PC | 1 |
2 other study(ies) available for phthalocyanine and Hypoxia
| Article | Year |
|---|---|
In Vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer.
Topics: Albumins; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Humans; Hypoxia; Immunotherapy; Indoles; Isoindoles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Prodrugs | 2021 |
Encapsulating an acid-activatable phthalocyanine-doxorubicin conjugate and the hypoxia-sensitive tirapazamine in polymeric micelles for multimodal cancer therapy.
Topics: Animals; Doxorubicin; Hypoxia; Indoles; Isoindoles; Mice; Mice, Nude; Micelles; Neoplasms; Polyethylene Glycols; Tirapazamine | 2021 |